Skip to main content

Discovery Immunology celebrates first anniversary

Discovery Immunology journal

Discovery Immunology is one! Last year, the British Society for Immunology launched our first broad-scope Open Access journal for new discoveries in cellular and molecular immunology.

The editorial team, led by Professor Simon Milling, have been working hard to bring you high-quality articles from leading researchers worldwide. Thanks to the incredible support of our editors, authors and readers the journal has built strong foundations for future success, earlier this year achieving indexing in the Directory of Open Access Journals (DOAJ).

In a new Editorial, Founding Editor-in-Chief Professor Milling reflects on the first full year for the journal and highlights some of the most impactful content published so far.

Explore the first full issue

Discovery Immunology's first full volume features cutting-edge original research, insightful reviews and short reports describing novel mechanisms controlling the immune response. These Open Access articles cover the spectrum of cellular and molecular immunology research, from the developmental trajectories of monocytes to deadly interactions between NK cells and CD4 T cells

Lots more exciting content is in the pipeline, including the journal's first Special Collections, which will focus on ecoimmunology, mononuclear cells, checkpoint molecules and T cells at barrier sites. If your research is in one of these areas, why not submit your article to join a collection? Read the calls for papers to find out more or contact our editorial team at

Submit your work

Discovery Immunology welcomes original research, review papers, commentaries, perspectives and invited editorials describing novel mechanisms controlling the immune response. The journal also considers short reports that describe significant advances in an area of immunology.

We’re proud to offer a 20% discount on publication fees for BSI members. As part of the BSI journal family, Discovery Immunology joins our other fully Open Access journal Immunotherapy Advances, which was recently accepted into ESCI, and Clinical & Experimental Immunology, our long-standing hybrid journal.

We invite our members and the wider immunology community to support the Society and consider submitting your work.

Find out more